Health in Work - a Measure for Increased Coping and Work Inclusion
HiAforsk
1 other identifier
interventional
1,383
1 country
1
Brief Summary
Health in work - a measure for increased coping and work participation
- An effect analysis of a health- and work environment intervention at the workplace. Part 1:quantitative data collection The main objective of this study is to investigate the effect of the workplace intervention in the new Norwegian national programme Health in work (HelseIArbeid) through a pragmatic cluster-randomized study. The main hypothesis is that this interdisciplinary health and welfare intervention at the workplace reduces sick leave and improves mastering of common health problems more efficiently than a conventional welfare intervention. More specifically, it is hypothesized that the Health in work intervention has a better cost-effectiveness in terms of sick leave, use of health services and coping with common health problems indicated by an increased health-related quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 11, 2019
CompletedStudy Start
First participant enrolled
June 14, 2019
CompletedFirst Posted
Study publicly available on registry
June 27, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2035
ExpectedDecember 16, 2024
December 1, 2024
4 years
June 11, 2019
December 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change in overall sickness absence rates (self- and physician-certified) at the workplace (unit level)
Sickness absence data from workplace-registers; Difference-in-difference analyses of sickness absence within and between intervention and control group (% of planned workdays).
Time period 24 months prior to randomization compared to the time period 12-24 months after randomization
Change in healthcare utilization
Difference-in-difference analyses of health service refunds from National register of control and health service refunds (KUHR database, Helsedirektoratet) and Norwegian Patient Register (NPR, Helsedirektoratet) within and between intervention and control group.
Time period 24 months prior to randomization compared to the time period 12-24 months after randomization
Change in health-related quality of life (HRQoL) by EQ-5D-5L utility value, including EQ-VAS score
Difference-in-difference analyses of HRQoL within and between intervention and control groups by use of EQ-5D/EQ-VAS.The EuroQol descriptive system EQ-5D-5L describes health along five dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression). Participants rate each dimension along five severity levels from no problems (1) to extreme problems (5).The resulting combination (5 to the power of 5 = 3,125 possible combinations) is attached a utility value based on a national value set on a scale from 1(best health) to a 0(or even lower) for worst health.A Norwegian value set is currently being developed.The EQ-VAS (EuroQol vertical visual analogue scale;0 as worst,100 as best possible score) is an integral part that has to be included when using the EQ-5D questionnaire.It offers important, complementary information on respondents' valuations of their HRQoL that are not necessarily captured by use of the 5 dimensional descriptive part of this instrument.
Enrollment (Q1) to 12 months (Q2) and 24 months (Q3) after randomization
Health-economic analyses
Cost-effectiveness analysis based on primary outcome 3 and cost-benefit analyses based on primary outcome 1 and 2. Comparing the intervention arms in terms of incremental costs based on direct- and indirect costs related to interventions throughout the intervention period.
Time period 24 months prior to randomization through 24 months after randomization
Secondary Outcomes (8)
Change in physician-certified sickness absence rates (individual level)
Time period 24 months prior to randomization compared to the time period 12-24 months after randomization
Change in self-certified sickness absence rates (individual level)
Enrollment (Q1) to 12 months (Q2) and 24 months (Q3) after randomization
Change in psychosocial work environment by Demand-Control-Support-Questionnaire score
Enrollment (Q1) to 12 months (Q2) and 24 months (Q3) after randomization
Change in social support from colleagues by NDSS-16 score
Enrollment (Q1) to 12 months (Q2) and 24 months (Q3) after randomization
Change in job satisfaction by GJS score
Enrollment (Q1) to 12 months (Q2) and 24 months (Q3) after randomization
- +3 more secondary outcomes
Study Arms (2)
Health in work
EXPERIMENTALThe interdisciplinary Health in work intervention consists of three information sessions over the course of one year, with work place processes in between. In the meetings, structured health information about musculoskeletal- and mental disorders is given and put in the context of working and the specific workplace. It is an integrated intervention where information is given together by both healthcare- and NAV-personnel.
Regular work place measures
ACTIVE COMPARATORRegular work place measures offered by NAV workplace service. Those are interventions given by NAV personnel without healthcare involvement and can be varying.
Interventions
see arm/group description
Eligibility Criteria
You may qualify if:
- minimum 8 employees
- all staff employed \> 20% in the participating workplaces/workplace units
- Norwegian-speaking
You may not qualify if:
- \- ongoing profound reorganisation at the workplace/workplace unit (\>20% change of employees within workplace unit)
- \- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital of North Norwaylead
- University of Tromsocollaborator
- Norwegian Labour and Welfare Administrationcollaborator
- Helse Nordcollaborator
Study Sites (1)
University Hospital of Nothern Norway
Tromsø, Norway
Related Publications (2)
Hoper AC, Terjesen CL, Fleten N. Comparing the New Interdisciplinary Health in Work Intervention With Conventional Monodisciplinary Welfare Interventions at Norwegian Workplaces: Protocol for a Pragmatic Cluster Randomized Trial. JMIR Res Protoc. 2022 Apr 7;11(4):e36166. doi: 10.2196/36166.
PMID: 35388792BACKGROUNDTerjesen CL, Hoper AC, Farbu EH, Olsen JA, Fleten N. Impact of an intersectoral universal workplace intervention on health related quality of life and wellbeing in a pragmatic cluster randomised trial. Sci Rep. 2025 Jul 29;15(1):27715. doi: 10.1038/s41598-025-12221-1.
PMID: 40730635DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Nils Fleten, Phd
UiT The artic University of Norway / Norwegian Welfare Service Troms
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
June 11, 2019
First Posted
June 27, 2019
Study Start
June 14, 2019
Primary Completion
July 1, 2023
Study Completion (Estimated)
July 1, 2035
Last Updated
December 16, 2024
Record last verified: 2024-12